
Our Research in Oncology
Cancer is one of the world’s biggest healthcare challenges. Almost everyone has a close experience of cancer in their lifetime, whether as a patient, relative, or caregiver.
Despite recent advances in cancer immunotherapy, about 80% of patients still do not respond or become resistant to current immuno-oncology treatments. At Astellas, our goal is to find new ways to help the immune system recognize and fight tumors better.
Targeted protein degradation (TPD) is another promising approach. It can change how we treat many diseases, like cancer, by breaking down disease targets that were once thought to be “undruggable.” Protein degraders use the body’s natural system to get rid of harmful proteins that other treatments can’t affect.
We are building on our strong heritage in oncology, using our teams’ talent and skills to change cancer treatment for those who need it most. We dedicate our collective strengths to find new ways to treat and eventually cure patients with cancer.